Global Insulin Like Growth Factor 1 Receptor Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Insulin Like Growth Factor 1 Receptor Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Insulin Like Growth Factor 1 Receptor by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Insulin Like Growth Factor 1 Receptor by Country/Region, 2017, 2022 & 2028

2.2 Insulin Like Growth Factor 1 Receptor Segment by Type

2.2.1 BI-893923

2.2.2 CT-707

2.2.3 1R-E1

2.2.4 ATL-1101

2.2.5 Others

2.3 Insulin Like Growth Factor 1 Receptor Sales by Type

2.3.1 Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2017-2022)

2.3.2 Global Insulin Like Growth Factor 1 Receptor Revenue and Market Share by Type (2017-2022)

2.3.3 Global Insulin Like Growth Factor 1 Receptor Sale Price by Type (2017-2022)

2.4 Insulin Like Growth Factor 1 Receptor Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Others

2.5 Insulin Like Growth Factor 1 Receptor Sales by Application

2.5.1 Global Insulin Like Growth Factor 1 Receptor Sale Market Share by Application (2017-2022)

2.5.2 Global Insulin Like Growth Factor 1 Receptor Revenue and Market Share by Application (2017-2022)

2.5.3 Global Insulin Like Growth Factor 1 Receptor Sale Price by Application (2017-2022)

3 Global Insulin Like Growth Factor 1 Receptor by Company

3.1 Global Insulin Like Growth Factor 1 Receptor Breakdown Data by Company

3.1.1 Global Insulin Like Growth Factor 1 Receptor Annual Sales by Company (2020-2022)

3.1.2 Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Company (2020-2022)

3.2 Global Insulin Like Growth Factor 1 Receptor Annual Revenue by Company (2020-2022)

3.2.1 Global Insulin Like Growth Factor 1 Receptor Revenue by Company (2020-2022)

3.2.2 Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Company (2020-2022)

3.3 Global Insulin Like Growth Factor 1 Receptor Sale Price by Company

3.4 Key Manufacturers Insulin Like Growth Factor 1 Receptor Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Insulin Like Growth Factor 1 Receptor Product Location Distribution

3.4.2 Players Insulin Like Growth Factor 1 Receptor Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Insulin Like Growth Factor 1 Receptor by Geographic Region

4.1 World Historic Insulin Like Growth Factor 1 Receptor Market Size by Geographic Region (2017-2022)

4.1.1 Global Insulin Like Growth Factor 1 Receptor Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Insulin Like Growth Factor 1 Receptor Annual Revenue by Geographic Region

4.2 World Historic Insulin Like Growth Factor 1 Receptor Market Size by Country/Region (2017-2022)

4.2.1 Global Insulin Like Growth Factor 1 Receptor Annual Sales by Country/Region (2017-2022)

4.2.2 Global Insulin Like Growth Factor 1 Receptor Annual Revenue by Country/Region

4.3 Americas Insulin Like Growth Factor 1 Receptor Sales Growth

4.4 APAC Insulin Like Growth Factor 1 Receptor Sales Growth

4.5 Europe Insulin Like Growth Factor 1 Receptor Sales Growth

4.6 Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales Growth

5 Americas

5.1 Americas Insulin Like Growth Factor 1 Receptor Sales by Country

5.1.1 Americas Insulin Like Growth Factor 1 Receptor Sales by Country (2017-2022)

5.1.2 Americas Insulin Like Growth Factor 1 Receptor Revenue by Country (2017-2022)

5.2 Americas Insulin Like Growth Factor 1 Receptor Sales by Type

5.3 Americas Insulin Like Growth Factor 1 Receptor Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Insulin Like Growth Factor 1 Receptor Sales by Region

6.1.1 APAC Insulin Like Growth Factor 1 Receptor Sales by Region (2017-2022)

6.1.2 APAC Insulin Like Growth Factor 1 Receptor Revenue by Region (2017-2022)

6.2 APAC Insulin Like Growth Factor 1 Receptor Sales by Type

6.3 APAC Insulin Like Growth Factor 1 Receptor Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Insulin Like Growth Factor 1 Receptor by Country

7.1.1 Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2017-2022)

7.1.2 Europe Insulin Like Growth Factor 1 Receptor Revenue by Country (2017-2022)

7.2 Europe Insulin Like Growth Factor 1 Receptor Sales by Type

7.3 Europe Insulin Like Growth Factor 1 Receptor Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Insulin Like Growth Factor 1 Receptor by Country

8.1.1 Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales by Country (2017-2022)

8.1.2 Middle East & Africa Insulin Like Growth Factor 1 Receptor Revenue by Country (2017-2022)

8.2 Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales by Type

8.3 Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Insulin Like Growth Factor 1 Receptor

10.3 Manufacturing Process Analysis of Insulin Like Growth Factor 1 Receptor

10.4 Industry Chain Structure of Insulin Like Growth Factor 1 Receptor

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Insulin Like Growth Factor 1 Receptor Distributors

11.3 Insulin Like Growth Factor 1 Receptor Customer

12 World Forecast Review for Insulin Like Growth Factor 1 Receptor by Geographic Region

12.1 Global Insulin Like Growth Factor 1 Receptor Market Size Forecast by Region

12.1.1 Global Insulin Like Growth Factor 1 Receptor Forecast by Region (2023-2028)

12.1.2 Global Insulin Like Growth Factor 1 Receptor Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Insulin Like Growth Factor 1 Receptor Forecast by Type

12.7 Global Insulin Like Growth Factor 1 Receptor Forecast by Application

13 Key Players Analysis

13.1 Astellas Pharma Inc.

13.1.1 Astellas Pharma Inc. Company Information

13.1.2 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Product Offered

13.1.3 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Astellas Pharma Inc. Main Business Overview

13.1.5 Astellas Pharma Inc. Latest Developments

13.2 AstraZeneca Plc

13.2.1 AstraZeneca Plc Company Information

13.2.2 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Product Offered

13.2.3 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AstraZeneca Plc Main Business Overview

13.2.5 AstraZeneca Plc Latest Developments

13.3 Axelar AB

13.3.1 Axelar AB Company Information

13.3.2 Axelar AB Insulin Like Growth Factor 1 Receptor Product Offered

13.3.3 Axelar AB Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Axelar AB Main Business Overview

13.3.5 Axelar AB Latest Developments

13.4 Boehringer Ingelheim GmbH

13.4.1 Boehringer Ingelheim GmbH Company Information

13.4.2 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Product Offered

13.4.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Boehringer Ingelheim GmbH Main Business Overview

13.4.5 Boehringer Ingelheim GmbH Latest Developments

13.5 Bristol-Myers Squibb Company

13.5.1 Bristol-Myers Squibb Company Company Information

13.5.2 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Product Offered

13.5.3 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Bristol-Myers Squibb Company Main Business Overview

13.5.5 Bristol-Myers Squibb Company Latest Developments

13.6 Eli Lilly and Company

13.6.1 Eli Lilly and Company Company Information

13.6.2 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Product Offered

13.6.3 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Eli Lilly and Company Main Business Overview

13.6.5 Eli Lilly and Company Latest Developments

13.7 F. Hoffmann-La Roche Ltd.

13.7.1 F. Hoffmann-La Roche Ltd. Company Information

13.7.2 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Product Offered

13.7.3 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 F. Hoffmann-La Roche Ltd. Main Business Overview

13.7.5 F. Hoffmann-La Roche Ltd. Latest Developments

13.8 Genmab A/S

13.8.1 Genmab A/S Company Information

13.8.2 Genmab A/S Insulin Like Growth Factor 1 Receptor Product Offered

13.8.3 Genmab A/S Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Genmab A/S Main Business Overview

13.8.5 Genmab A/S Latest Developments

13.9 Immunomedics, Inc.

13.9.1 Immunomedics, Inc. Company Information

13.9.2 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Product Offered

13.9.3 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Immunomedics, Inc. Main Business Overview

13.9.5 Immunomedics, Inc. Latest Developments

13.10 Insmed Incorporated

13.10.1 Insmed Incorporated Company Information

13.10.2 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Product Offered

13.10.3 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Insmed Incorporated Main Business Overview

13.10.5 Insmed Incorporated Latest Developments

13.11 Merck & Co., Inc.

13.11.1 Merck & Co., Inc. Company Information

13.11.2 Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Product Offered

13.11.3 Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Merck & Co., Inc. Main Business Overview

13.11.5 Merck & Co., Inc. Latest Developments

13.12 Merrimack Pharmaceuticals, Inc.

13.12.1 Merrimack Pharmaceuticals, Inc. Company Information

13.12.2 Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Product Offered

13.12.3 Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Merrimack Pharmaceuticals, Inc. Main Business Overview

13.12.5 Merrimack Pharmaceuticals, Inc. Latest Developments

13.13 Novartis AG

13.13.1 Novartis AG Company Information

13.13.2 Novartis AG Insulin Like Growth Factor 1 Receptor Product Offered

13.13.3 Novartis AG Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Novartis AG Main Business Overview

13.13.5 Novartis AG Latest Developments

13.14 PharmAbcine, Inc.

13.14.1 PharmAbcine, Inc. Company Information

13.14.2 PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Product Offered

13.14.3 PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 PharmAbcine, Inc. Main Business Overview

13.14.5 PharmAbcine, Inc. Latest Developments

13.15 ProteoThera, Inc.

13.15.1 ProteoThera, Inc. Company Information

13.15.2 ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Product Offered

13.15.3 ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 ProteoThera, Inc. Main Business Overview

13.15.5 ProteoThera, Inc. Latest Developments

14 Research Findings and Conclusion

Table 1. Insulin Like Growth Factor 1 Receptor Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Insulin Like Growth Factor 1 Receptor Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of BI-893923

Table 4. Major Players of CT-707

Table 5. Major Players of 1R-E1

Table 6. Major Players of ATL-1101

Table 7. Major Players of Others

Table 8. Global Insulin Like Growth Factor 1 Receptor Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2017-2022)

Table 10. Global Insulin Like Growth Factor 1 Receptor Revenue by Type (2017-2022) & ($ million)

Table 11. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type (2017-2022)

Table 12. Global Insulin Like Growth Factor 1 Receptor Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2017-2022) & (K Pcs)

Table 14. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2017-2022)

Table 15. Global Insulin Like Growth Factor 1 Receptor Revenue by Application (2017-2022)

Table 16. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application (2017-2022)

Table 17. Global Insulin Like Growth Factor 1 Receptor Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Insulin Like Growth Factor 1 Receptor Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Company (2020-2022)

Table 20. Global Insulin Like Growth Factor 1 Receptor Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Company (2020-2022)

Table 22. Global Insulin Like Growth Factor 1 Receptor Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Insulin Like Growth Factor 1 Receptor Producing Area Distribution and Sales Area

Table 24. Players Insulin Like Growth Factor 1 Receptor Products Offered

Table 25. Insulin Like Growth Factor 1 Receptor Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Insulin Like Growth Factor 1 Receptor Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Insulin Like Growth Factor 1 Receptor Sales Market Share Geographic Region (2017-2022)

Table 30. Global Insulin Like Growth Factor 1 Receptor Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Insulin Like Growth Factor 1 Receptor Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Country/Region (2017-2022)

Table 34. Global Insulin Like Growth Factor 1 Receptor Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Insulin Like Growth Factor 1 Receptor Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2017-2022)

Table 38. Americas Insulin Like Growth Factor 1 Receptor Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country (2017-2022)

Table 40. Americas Insulin Like Growth Factor 1 Receptor Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2017-2022)

Table 42. Americas Insulin Like Growth Factor 1 Receptor Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2017-2022)

Table 44. APAC Insulin Like Growth Factor 1 Receptor Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Insulin Like Growth Factor 1 Receptor Sales Market Share by Region (2017-2022)

Table 46. APAC Insulin Like Growth Factor 1 Receptor Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Insulin Like Growth Factor 1 Receptor Revenue Market Share by Region (2017-2022)

Table 48. APAC Insulin Like Growth Factor 1 Receptor Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2017-2022)

Table 50. APAC Insulin Like Growth Factor 1 Receptor Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2017-2022)

Table 52. Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2017-2022)

Table 54. Europe Insulin Like Growth Factor 1 Receptor Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country (2017-2022)

Table 56. Europe Insulin Like Growth Factor 1 Receptor Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2017-2022)

Table 58. Europe Insulin Like Growth Factor 1 Receptor Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Insulin Like Growth Factor 1 Receptor Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Insulin Like Growth Factor 1 Receptor

Table 69. Key Market Challenges & Risks of Insulin Like Growth Factor 1 Receptor

Table 70. Key Industry Trends of Insulin Like Growth Factor 1 Receptor

Table 71. Insulin Like Growth Factor 1 Receptor Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Insulin Like Growth Factor 1 Receptor Distributors List

Table 74. Insulin Like Growth Factor 1 Receptor Customer List

Table 75. Global Insulin Like Growth Factor 1 Receptor Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Insulin Like Growth Factor 1 Receptor Sales Market Forecast by Region

Table 77. Global Insulin Like Growth Factor 1 Receptor Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Insulin Like Growth Factor 1 Receptor Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Insulin Like Growth Factor 1 Receptor Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Insulin Like Growth Factor 1 Receptor Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Insulin Like Growth Factor 1 Receptor Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Insulin Like Growth Factor 1 Receptor Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Insulin Like Growth Factor 1 Receptor Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Insulin Like Growth Factor 1 Receptor Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Insulin Like Growth Factor 1 Receptor Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Insulin Like Growth Factor 1 Receptor Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Insulin Like Growth Factor 1 Receptor Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Insulin Like Growth Factor 1 Receptor Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global Insulin Like Growth Factor 1 Receptor Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Insulin Like Growth Factor 1 Receptor Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share Forecast by Application (2023-2028)

Table 95. Astellas Pharma Inc. Basic Information, Insulin Like Growth Factor 1 Receptor Manufacturing Base, Sales Area and Its Competitors

Table 96. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Product Offered

Table 97. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. Astellas Pharma Inc. Main Business

Table 99. Astellas Pharma Inc. Latest Developments

Table 100. AstraZeneca Plc Basic Information, Insulin Like Growth Factor 1 Receptor Manufacturing Base, Sales Area and Its Competitors

Table 101. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Product Offered

Table 102. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. AstraZeneca Plc Main Business

Table 104. AstraZeneca Plc Latest Developments

Table 105. Axelar AB Basic Information, Insulin Like Growth Factor 1 Receptor Manufacturing Base, Sales Area and Its Competitors

Table 106. Axelar AB Insulin Like Growth Factor 1 Receptor Product Offered

Table 107. Axelar AB Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. Axelar AB Main Business

Table 109. Axelar AB Latest Developments

Table 110. Boehringer Ingelheim GmbH Basic Information, Insulin Like Growth Factor 1 Receptor Manufacturing Base, Sales Area and Its Competitors

Table 111. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Product Offered

Table 112. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. Boehringer Ingelheim GmbH Main Business

Table 114. Boehringer Ingelheim GmbH Latest Developments

Table 115. Bristol-Myers Squibb Company Basic Information, Insulin Like Growth Factor 1 Receptor Manufacturing Base, Sales Area and Its Competitors

Table 116. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Product Offered

Table 117. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Bristol-Myers Squibb Company Main Business

Table 119. Bristol-Myers Squibb Company Latest Developments

Table 120. Eli Lilly and Company Basic Information, Insulin Like Growth Factor 1 Receptor Manufacturing Base, Sales Area and Its Competitors

Table 121. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Product Offered

Table 122. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. Eli Lilly and Company Main Business

Table 124. Eli Lilly and Company Latest Developments

Table 125. F. Hoffmann-La Roche Ltd. Basic Information, Insulin Like Growth Factor 1 Receptor Manufacturing Base, Sales Area and Its Competitors

Table 126. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Product Offered

Table 127. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. F. Hoffmann-La Roche Ltd. Main Business

Table 129. F. Hoffmann-La Roche Ltd. Latest Developments

Table 130. Genmab A/S Basic Information, Insulin Like Growth Factor 1 Receptor Manufacturing Base, Sales Area and Its Competitors

Table 131. Genmab A/S Insulin Like Growth Factor 1 Receptor Product Offered

Table 132. Genmab A/S Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 133. Genmab A/S Main Business

Table 134. Genmab A/S Latest Developments

Table 135. Immunomedics, Inc. Basic Information, Insulin Like Growth Factor 1 Receptor Manufacturing Base, Sales Area and Its Competitors

Table 136. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Product Offered

Table 137. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 138. Immunomedics, Inc. Main Business

Table 139. Immunomedics, Inc. Latest Developments

Table 140. Insmed Incorporated Basic Information, Insulin Like Growth Factor 1 Receptor Manufacturing Base, Sales Area and Its Competitors

Table 141. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Product Offered

Table 142. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 143. Insmed Incorporated Main Business

Table 144. Insmed Incorporated Latest Developments

Table 145. Merck & Co., Inc. Basic Information, Insulin Like Growth Factor 1 Receptor Manufacturing Base, Sales Area and Its Competitors

Table 146. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Product Offered

Table 147. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 148. Merck & Co., Inc. Main Business

Table 149. Merck & Co., Inc. Latest Developments

Table 150. Merrimack Pharmaceuticals, Inc. Basic Information, Insulin Like Growth Factor 1 Receptor Manufacturing Base, Sales Area and Its Competitors

Table 151. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Product Offered

Table 152. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 153. Merrimack Pharmaceuticals, Inc. Main Business

Table 154. Merrimack Pharmaceuticals, Inc. Latest Developments

Table 155. Novartis AG Basic Information, Insulin Like Growth Factor 1 Receptor Manufacturing Base, Sales Area and Its Competitors

Table 156. Novartis AG Insulin Like Growth Factor 1 Receptor Product Offered

Table 157. Novartis AG Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 158. Novartis AG Main Business

Table 159. Novartis AG Latest Developments

Table 160. PharmAbcine, Inc. Basic Information, Insulin Like Growth Factor 1 Receptor Manufacturing Base, Sales Area and Its Competitors

Table 161. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Product Offered

Table 162. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 163. PharmAbcine, Inc. Main Business

Table 164. PharmAbcine, Inc. Latest Developments

Table 165. ProteoThera, Inc. Basic Information, Insulin Like Growth Factor 1 Receptor Manufacturing Base, Sales Area and Its Competitors

Table 166. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Product Offered

Table 167. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 168. ProteoThera, Inc. Main Business

Table 169. ProteoThera, Inc. Latest Developments

List of Figures

Figure 1. Picture of Insulin Like Growth Factor 1 Receptor

Figure 2. Insulin Like Growth Factor 1 Receptor Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Insulin Like Growth Factor 1 Receptor Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Insulin Like Growth Factor 1 Receptor Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Insulin Like Growth Factor 1 Receptor Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of BI-893923

Figure 10. Product Picture of CT-707

Figure 11. Product Picture of 1R-E1

Figure 12. Product Picture of ATL-1101

Figure 13. Product Picture of Others

Figure 14. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type in 2021

Figure 15. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type (2017-2022)

Figure 16. Insulin Like Growth Factor 1 Receptor Consumed in Hospital

Figure 17. Global Insulin Like Growth Factor 1 Receptor Market: Hospital (2017-2022) & (K Pcs)

Figure 18. Insulin Like Growth Factor 1 Receptor Consumed in Clinic

Figure 19. Global Insulin Like Growth Factor 1 Receptor Market: Clinic (2017-2022) & (K Pcs)

Figure 20. Insulin Like Growth Factor 1 Receptor Consumed in Others

Figure 21. Global Insulin Like Growth Factor 1 Receptor Market: Others (2017-2022) & (K Pcs)

Figure 22. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2017-2022)

Figure 23. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application in 2021

Figure 24. Insulin Like Growth Factor 1 Receptor Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Company in 2021

Figure 26. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Geographic Region in 2021

Figure 28. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Region (2017-2022)

Figure 29. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country/Region in 2021

Figure 30. Americas Insulin Like Growth Factor 1 Receptor Sales 2017-2022 (K Pcs)

Figure 31. Americas Insulin Like Growth Factor 1 Receptor Revenue 2017-2022 ($ Millions)

Figure 32. APAC Insulin Like Growth Factor 1 Receptor Sales 2017-2022 (K Pcs)

Figure 33. APAC Insulin Like Growth Factor 1 Receptor Revenue 2017-2022 ($ Millions)

Figure 34. Europe Insulin Like Growth Factor 1 Receptor Sales 2017-2022 (K Pcs)

Figure 35. Europe Insulin Like Growth Factor 1 Receptor Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales 2017-2022 (K Pcs)

Figure 37. Middle East & Africa Insulin Like Growth Factor 1 Receptor Revenue 2017-2022 ($ Millions)

Figure 38. Americas Insulin Like Growth Factor 1 Receptor Sales Market Share by Country in 2021

Figure 39. Americas Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country in 2021

Figure 40. United States Insulin Like Growth Factor 1 Receptor Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Insulin Like Growth Factor 1 Receptor Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Insulin Like Growth Factor 1 Receptor Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Insulin Like Growth Factor 1 Receptor Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Insulin Like Growth Factor 1 Receptor Sales Market Share by Region in 2021

Figure 45. APAC Insulin Like Growth Factor 1 Receptor Revenue Market Share by Regions in 2021

Figure 46. China Insulin Like Growth Factor 1 Receptor Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Insulin Like Growth Factor 1 Receptor Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Insulin Like Growth Factor 1 Receptor Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Insulin Like Growth Factor 1 Receptor Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Insulin Like Growth Factor 1 Receptor Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Insulin Like Growth Factor 1 Receptor Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share by Country in 2021

Figure 53. Europe Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country in 2021

Figure 54. Germany Insulin Like Growth Factor 1 Receptor Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Insulin Like Growth Factor 1 Receptor Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Insulin Like Growth Factor 1 Receptor Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Insulin Like Growth Factor 1 Receptor Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Insulin Like Growth Factor 1 Receptor Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country in 2021

Figure 61. Egypt Insulin Like Growth Factor 1 Receptor Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Insulin Like Growth Factor 1 Receptor Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Insulin Like Growth Factor 1 Receptor Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Insulin Like Growth Factor 1 Receptor Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Insulin Like Growth Factor 1 Receptor Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Insulin Like Growth Factor 1 Receptor in 2021

Figure 67. Manufacturing Process Analysis of Insulin Like Growth Factor 1 Receptor

Figure 68. Industry Chain Structure of Insulin Like Growth Factor 1 Receptor

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles